2 GLP-1 medications can promote a healthier balance in your gut, and have the potential to decrease harmful bacteria, increase beneficial bacteria, and reverse the unhealthy shifts caused by obesity
Phase 3 data (TRIUMPH-4) showed average weight loss of 28.7% body weight at the 12mg dose over 68 weeks, equivalent to approximately 71.2 pounds from an average starting weight of 248.5 pounds
This distinction matters, as two patients prescribed the same dose in milligrams may draw different volumes if their vials have different concentrations
Populations with a low frequency of the HLA-B27 gene variant have a correspondingly low occurrence of ankylosing spondylitis
Weight loss with retatrutide varies from person to person
They arrive at the gym later feeling weaker, deflated, sometimes lightheaded or unwell